Skip to main content

Table 1 Prostatic morphometric and stereological evaluation

From: Harmful effects of carbamazepine on the postnatal development of the rat ventral prostate

Groups

Absolute prostatic weight

(mg)

Relative prostatic weight

(mg/100 g b.w.)

Prostatic volume (mm3)

Lvgt(1/mm2)

Lgt(mm)

C43

110.50 ± 26.25

66.11 ± 14.38

110.50 ± 26.25

27.10 ± 5.61

2,97 ± 0.84

CBZ43

87.60 ± 8.56

60.08 ± 3.83

87.60 ± 8.56

32.70 ± 6.56

2.89 ± 0.77

C63

245.72 ± 21.64

83.80 ± 7.95

245.72 ± 21.64

23.10 ± 2.36

5.71 ± 1.05

CBZ63

231.00 ± 9.17

81.48 ± 5.91

231.00 ± 9.17

20.40 ± 5.99

4.70 ± 1.35

C93

423.08 ± 74.44

12.24 ± 0.32

423.08 ± 74.44

19.10 ± 2.75

8.07 ± 1.79

CBZ93

260.24 ± 46.80*

12.01 ± 0.67

260.24 ± 46.80*

21.50 ± 4.03

5.56 ± 1.47*

  1. Data are reported as mean ± SD.
  2. Differences statistically significant: *p ≤ 0.05
  3. Prostate absolute and relative weights, prostate volume, length density (Lvgt) and length (Lgt) of the prostate glandular tubules in the control and CBZ-treated groups